Tech Company Financing Transactions

EyeBio Funding Round

Bain Capital Life Sciences, Jeito Capital and MRL Ventures participated in a $65 million Series A funding round for EyeBio. The round closed on 11/14/2023.

Transaction Overview

Company Name
Announced On
11/14/2023
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Series A
Proceeds Purpose
The company intends to use the proceeds from the funding to accelerate its clinical development program and further build out its innovative retina pipeline.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
International Building 71 Kingsway
London, England, WC2B 6ST
UK
Phone
Undisclosed
Email Address
Overview
EyeBio is a clinical-stage ophthalmology biotech company that brings together an experienced team of leaders, innovators, and entrepreneurs to develop a new generation of therapies for eye diseases. We understand what it takes to establish a new standard of care in ophthalmology. Our co-founders, Dr. David Guyer and Dr. Anthony P. Adamis, created and led the company that introduced the first anti-vascular endothelial growth factor (anti-VEGF) therapy for patients with age-related macular degeneration (AMD).
Profile
EyeBio LinkedIn Company Profile
Social Media
EyeBio Company Twitter Account
Company News
EyeBio News
Facebook
EyeBio on Facebook
YouTube
EyeBio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Guyer
  David Guyer LinkedIn Profile  David Guyer Twitter Account  David Guyer News  David Guyer on Facebook
Chief Technical Officer
Joost Ouwerkerk
  Joost Ouwerkerk LinkedIn Profile  Joost Ouwerkerk Twitter Account  Joost Ouwerkerk News  Joost Ouwerkerk on Facebook
Co-Founder
Fred Lalonde
  Fred Lalonde LinkedIn Profile  Fred Lalonde Twitter Account  Fred Lalonde News  Fred Lalonde on Facebook
Co-Founder
Laurence Tosi
  Laurence Tosi LinkedIn Profile  Laurence Tosi Twitter Account  Laurence Tosi News  Laurence Tosi on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/14/2023: AristaMD venture capital transaction
Next: 11/14/2023: Aikido Security venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary